Drug Trial Radar · NCT03829241
Randomized Trial of Adult Participants With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: May 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
881
Actual
Start
Feb 19, 2019
Primary completion
Jan 14, 2020
Study completion May 8, 2020
Sponsor
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 4, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of troriluzole versus placebo in participants with generalized anxiety disorder.
Conditions
- Generalized Anxiety Disorder
Interventions
TroriluzoleDrug
100 mg capsule
PlaceboDrug
Placebo matched to troriluzole
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the HAM-A Total Score at Week 8Time frame: Baseline, Week 8
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research Group
Little Rock, Arkansas
Axiom Research, LLC
Colton, California
Pharmacology Research Institute
Encino, California
University of California, San Francisco-Fresno
Fresno, California
Collaborative Neuroscience Network, LLC.
Garden Grove, California
Synergy San Diego
Lemon Grove, California
Pharmacology Research Institute
Los Alamitos, California
CalNeuro Research Group
Los Angeles, California
Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners, LLC
Oakland, California
NRC Research Institute
Orange, California
Desert Valley Research
Rancho Mirage, California
Atemis Institute for Clinical Research
San Marcos, California
California Neuroscience Research Medical Group, Inc
Sherman Oaks, California
CNS Network
Torrance, California
Pacific Clinical Research Medical Group
Upland, California
Child Study Center at Yale University School of Medicine
New Haven, Connecticut
Comprehensive Psychiatric Care
Norwich, Connecticut
Meridien Research
Bradenton, Florida
Gulfcoast Clinical Research Center
Fort Myers, Florida
Galiz Research
Hialeah, Florida
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Harmony Clinical Research
North Miami Beach, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Stedman Clinical Trials
Tampa, Florida
iResearch Atlanta LLC
Decatur, Georgia
Northwest Behavioral Research Center
Marietta, Georgia
Phoenix Medical Research
Prairie Village, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Boston Clinical Trials
Boston, Massachusetts
BTC of New Bedford
New Bedford, Massachusetts
Altea Research Institute
Las Vegas, Nevada
Center for Emotional Fitness
Cherry Hill, New Jersey
Albuquerque Neuroscience Inc.
Albuquerque, New Mexico
SPRI Clinical Trials, LLC
Brooklyn, New York
Richmond Behavioral Associates
Staten Island, New York
New Hope Clinical Research
Charlotte, North Carolina
Midwest Clinical Research Center
Dayton, Ohio
IPS Research Company
Oklahoma City, Oklahoma
Summit Research Network (Oregon) Inc.
Portland, Oregon
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.